| Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study FD Dick, G De Palma, A Ahmadi, NW Scott, GJ Prescott, J Bennett, ... Occupational and environmental medicine 64 (10), 666-672, 2007 | 440 | 2007 |
| Biomarkers of oxidative stress after controlled human exposure to ozone M Corradi, R Alinovi, M Goldoni, MV Vettori, G Folesani, P Mozzoni, ... Toxicology letters 134 (1-3), 219-225, 2002 | 164 | 2002 |
| Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity W Magliani, S Conti, FD Bernardis, M Gerloni, D Bertolotti, P Mozzoni, ... Nature Biotechnology 15 (2), 155-158, 1997 | 164 | 1997 |
| Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects E Bergamaschi, G De Palma, P Mozzoni, S Vanni, MV Vettori, ... American journal of respiratory and critical care medicine 163 (6), 1426-1431, 2001 | 152 | 2001 |
| Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study FD Dick, G De Palma, A Ahmadi, A Osborne, NW Scott, GJ Prescott, ... Occupational and environmental medicine 64 (10), 673-680, 2007 | 132 | 2007 |
| Case-control study of interactions between genetic and environmental factors in Parkinson's disease G De Palma, P Mozzoni, A Mutti, S Calzetti, A Negrotti The Lancet 352 (9145), 1986-1987, 1998 | 104 | 1998 |
| Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers P Manini, G De Palma, R Andreoli, D Poli, P Mozzoni, G Folesani, A Mutti, ... Toxicology letters 167 (2), 142-151, 2006 | 102 | 2006 |
| Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress RR Alfieri, MA Bonelli, A Cavazzoni, M Brigotti, C Fumarola, P Sestili, ... The Journal of physiology 576 (2), 391-401, 2006 | 93 | 2006 |
| Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer P Mozzoni, I Banda, M Goldoni, M Corradi, M Tiseo, O Acampa, ... Biomarkers 18 (8), 679-686, 2013 | 92 | 2013 |
| Differential structural remodeling of the left‐atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: a … D Corradi, S Callegari, R Maestri, D Ferrara, D Mangieri, R Alinovi, ... Journal of Cardiovascular Electrophysiology 23 (3), 271-279, 2012 | 90 | 2012 |
| Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells R Alinovi, M Goldoni, S Pinelli, M Campanini, I Aliatis, D Bersani, ... Toxicology in Vitro 29 (3), 426-437, 2015 | 89 | 2015 |
| Occupational exposure to low levels of benzene: biomarkers of exposure and nucleic acid oxidation and their modulation by polymorphic xenobiotic metabolizing enzymes P Manini, G De Palma, R Andreoli, P Mozzoni, D Poli, M Goldoni, M Petyx, ... Toxicology letters 193 (3), 229-235, 2010 | 80 | 2010 |
| Welding fumes, a risk factor for lung diseases MG Riccelli, M Goldoni, D Poli, P Mozzoni, D Cavallo, M Corradi International journal of environmental research and public health 17 (7), 2552, 2020 | 74 | 2020 |
| Monogenic autoinflammatory diseases with mendelian inheritance: genes, mutations, and genotype/phenotype correlations D Martorana, F Bonatti, P Mozzoni, A Vaglio, A Percesepe Frontiers in immunology 8, 249422, 2017 | 68 | 2017 |
| Persistent lone atrial fibrillation: clinicopathologic study of 19 cases D Corradi, S Callegari, L Manotti, D Ferrara, M Goldoni, R Alinovi, ... Heart Rhythm 11 (7), 1250-1258, 2014 | 60 | 2014 |
| Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals L Buzio, G De Palma, P Mozzoni, M Tondel, C Buzio, I Franchini, ... Occupational and environmental medicine 60 (10), 789-793, 2003 | 60 | 2003 |
| Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids G De Palma, P Manini, P Mozzoni, R Andreoli, E Bergamaschi, ... Chemical research in toxicology 14 (10), 1393-1400, 2001 | 60 | 2001 |
| Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines RR Alfieri, M Galetti, S Tramonti, R Andreoli, P Mozzoni, A Cavazzoni, ... Molecular cancer 10, 1-14, 2011 | 59 | 2011 |
| Exhaled breath analysis in suspected cases of non-small-cell lung cancer: a cross-sectional study M Corradi, D Poli, I Banda, S Bonini, P Mozzoni, S Pinelli, R Alinovi, ... Journal of breath research 9 (2), 027101, 2015 | 56 | 2015 |
| Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC) M Tiseo, R Andreoli, F Gelsomino, P Mozzoni, C Azzoni, M Bartolotti, ... Lung cancer 83 (2), 265-271, 2014 | 53 | 2014 |
